Juliane Bernholz

Juliane Bernholz has held various leadership positions in pharmaceutical companies such as AM-Pharma, The Janssen Pharmaceutical Companies of Johnson & Johnson, Sanofi, Novartis Pharma AG, and Actelion. With a background in regulatory affairs, project management, and drug discovery, Juliane has extensive experience in areas such as infectious diseases, thrombosis, and critical care. Juliane holds a PhD in Cellbiology from the Biocenter, University of Basel, and has completed the IMD Board Director Diploma.